However, a significant challenge in evaluating kidney outcomes lies in the inconsistent definitions of renal endpoints across studies, particularly regarding the thresholds for substantial eGFR decline, which vary from 30% to 57%
As consumer awareness grows, GLP-1 has surpassed its pharmaceutical roots and is now more perceived as a symbol of metabolic health
Melanotic Schwannomas are rarely seen pigmented tumors with unpredictable prognosis and challenging diagnosis
When we see these high overturn rates, we don't have the authority currently to collect data on the number of approvals, denials or modifications through the
Compounded tirzepatide is advertised at $199/month, or about $298/month all-in
states to follow with their own proposals for color and food additive bans